For millions of French adults, a nightly pill is a routine—often taken for months, even years—viewed by some as a harmless sleep aid, a sort of “vitamin for sleep.” But growing evidence suggests a concerning link between long-term use of common sleep medications and an increased risk of dementia, including Alzheimer’s disease. While previously associated with dependency and falls, particularly in older adults, the impact of these medications on cognitive health is now coming into sharper focus.
France’s national health authorities, including the Agence Nationale de Sécurité du Médicament (ANSM) and the Haute Autorité de Santé (HAS), recommend that hypnotic drugs—specifically benzodiazepines and related medications—should not be used for more than four weeks to treat insomnia. However, a significant portion of the roughly 4 million French people who use sleep aids take them for extended periods. In 2012 alone, 134 million boxes of benzodiazepines or similar drugs were sold. Several large-scale studies have since illuminated a heightened risk of Alzheimer’s disease, potentially as high as 50%, among long-term users.
The Link Between Sleep Aids and Alzheimer’s: What the Studies Show
The medications in question are primarily hypnotics belonging to the benzodiazepine family and their “related” counterparts. According to the HAS, their effectiveness beyond 28 days becomes uncertain while the potential for adverse effects—including memory problems, daytime drowsiness, falls, accidents and dependence—increases. A Franco-Canadian study published in the BMJ found that cumulative use of these medications for more than three months increased the risk of developing Alzheimer’s disease by 43 to 51%. This risk was particularly pronounced with long-acting molecules and high cumulative doses, even after accounting for factors like anxiety, depression, and pre-existing sleep disorders.
Further research supports these findings. A study published in the Journal of Alzheimer’s Disease revealed that seniors using sleep aids at least five times per month had a 79% higher risk of dementia compared to non-users. The Fondation Médéric Alzheimer notes that studies indicate a 20 to 50% increased risk of Alzheimer’s disease with prolonged benzodiazepine use over several months. In absolute terms, the probability of having Alzheimer’s at age 75 is estimated at 17.8%, rising to between 21.4, and 26.7% in individuals exposed to these medications for extended periods.
How Sleep Aids May Compromise Memory
A key mechanism behind this increased risk lies in the anticholinergic properties of some of these medications. Anticholinergics block the action of acetylcholine, a neurotransmitter crucial for learning and memory consolidation. A large study published in JAMA Internal Medicine on strongly anticholinergic drugs also found an approximately 50% increase in the risk of dementia among highly exposed individuals. This blockage can manifest as difficulty concentrating, minor memory lapses, or a feeling of confusion, particularly in those over 65.
Beyond this, these hypnotics disrupt the natural architecture of sleep. They reduce the duration of sluggish-wave sleep, the deep sleep phase during which the brain’s glymphatic system clears metabolic waste products, including beta-amyloid, a protein associated with Alzheimer’s disease. Shortening this phase nightly may impair the brain’s ability to effectively eliminate these waste products. The HAS also highlights well-documented immediate effects, including daytime sleepiness, balance problems, falls, traffic accidents, and impaired memory performance on neuropsychological tests.
Safely Discontinuing Sleep Aids: A Practical Approach
The increased risk appears to be most significant with daily use over several months, particularly after age 65. For individuals who recognize themselves in this profile, abruptly stopping medication is not advisable. A “cold turkey” approach can lead to severe rebound insomnia, significant anxiety, and, in cases of high doses, even convulsions. Specialists recommend a gradual reduction, such as decreasing the dose by 25% every two weeks, adjusted on a case-by-case basis. A study relayed by the Fondation Médéric Alzheimer showed that in nursing homes, 43% of residents dependent on sleep aids for over 14 years were able to stop completely, and 26% were able to reduce their dosage without experiencing worse sleep.
- Consult with your doctor to assess the duration, dosage, and type of sleep aid you are taking.
- Together, establish a secure and progressive reduction schedule.
- Explore non-pharmacological alternatives: Cognitive Behavioral Therapy for Insomnia (CBT-I), sleep hygiene practices, and potentially prolonged-release melatonin or validated herbal remedies like valerian or eschscholzia.
The HAS and recommendations cited by the Vidal emphasize Cognitive Behavioral Therapy for Insomnia (CBT-I) as the first-line treatment for insomnia, with medications reserved for second-line use and short durations. CBT-I combines work on sleep-related thoughts, sleep restriction, and stimulus control, offering a lasting effect on sleep quality. Simple habits—regular schedules, daytime light exposure, physical activity, and limiting alcohol, caffeine, and screen time in the evening—also promote more natural sleep. It’s also important to note that certain sedating antihistamines marketed to aid sleep also possess anticholinergic properties and should be used with caution for those seeking to protect their memory.
The growing body of research underscores the importance of prioritizing sleep hygiene and exploring non-pharmacological approaches to insomnia. For those currently using sleep aids long-term, a conversation with a healthcare provider about a safe and gradual reduction plan is a crucial step in safeguarding cognitive health. The HAS continues to monitor these findings and will provide updated recommendations as new evidence emerges.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Have you or someone you realize been affected by long-term sleep aid use? Share your experiences and thoughts in the comments below. Please also share this article with anyone who might find this information helpful.
